Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(1)

MIXED(1)

Penpulimab combined with cetuximab

1 trial

phase_2

eye-ent-hospital-of-fudan-university

2 unique interventions2 categories

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting1

Other1

Role Distribution

Principal Investigator2

PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05260671Phase 2Recruiting

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Head and Neck NeoplasmsMetastatic CancerRecurrent Disease

PrincipalinvestigatorStart date: 2022-01-25

NCT04921995Phase 2Unknown

Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Chemotherapy EffectImmunotherapyRecurrent Nasopharyngeal Carcinoma+2 more

PrincipalinvestigatorStart date: 2019-04-15

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Chemotherapy Effect1 Head and Neck Neoplasms1 Immunotherapy1 Metastatic Cancer1 Recurrent Disease1 Recurrent Nasopharyngeal Carcinoma1 Stereotactic Body Radiation Therapy (SBRT)1 Unresectable Nasopharyngeal Carcinoma1

Affiliations

Eye & ENT Hospital of Fudan University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lizhi Niu, PhD

Fuda Cancer Hospital

31 trials

Shared therapeutic areas:

Head and Neck Neoplasms

Similarity Score4%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

11 trials

Shared therapeutic areas:

Chemotherapy Effect

Similarity Score4%

Shimon Slavin, MD

Hadassah Medical Organization

10 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Naiyer Rizvi, MD

Memorial Sloan Kettering Cancer Center

9 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

13 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Hagop Youssoufian, MD

Verastem, Inc.

20 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Kathy S. Albain, MD

Loyola University

9 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Lei Li, M.D.

Peking Union Medical College Hospital

46 trials

Shared therapeutic areas:

Immunotherapy

Similarity Score4%

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

Metastatic Cancer

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05260671Phase 2PrincipalInvestigator

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Head and Neck NeoplasmsMetastatic CancerRecurrent Disease

Recruiting

NCT04921995Phase 2PrincipalInvestigator

Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Chemotherapy EffectImmunotherapyRecurrent Nasopharyngeal Carcinoma+2 more

Unknown

All 2 trials loaded